SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company
Go back to SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company| Blue Calypso, Inc. Common (NASDAQ: BCYP) | Delayed: 8.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.44 | 52 Week High | $3.80 | |||
| Open | $0.00 | 52 Week Low | $0.50 | |||
| Day High | $8.44 | P/E | N/A | |||
| Day Low | $8.44 | EPS | $-0.08 | |||
| Volume | 9,125,409 | |||||
| (NASDAQ: SABS) | Delayed: 3.79 +0.09 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.70 | 52 Week High | $ | |||
| Open | $3.74 | 52 Week Low | $ | |||
| Day High | $3.83 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $ | |||
| Volume | 125,651 | |||||
